PDT Partners’s Sight Sciences SGHT Stock Holding History

PDT Partners’s Portfolio SGHT Stock Details SGHT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-15,971	Closed	-$132K	–	671
2023 Q2	$132K	Hold	15,971	–	–	0.02%	523
2023 Q1	$140K	Buy	15,971 +1,786	+13%	+$19.8K	0.02%	522
2022 Q4	$173K	Buy	+14,185	New	+$135K	0.03%	553

Other funds holding SGHT

DCP

D1 Capital Partners New York $11.2B AUM 15.78% 1-Year Est. Return

KCK Ltd Hamilton, Bermuda $15.1M AUM 30.14% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

AMH

Apollo Management Holdings New York $7.6B AUM 23.97% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PDT Partners's SGHT Position: Q3 2023 in Review

PDT Partners sold out of Sight Sciences (SGHT) in Q3 2023, closing a stake of 15,971 shares — an estimated $132K sold.

PDT Partners first reported a position in SGHT in Q4 2022 and held it in 3 quarters. The position peaked at $173K in Q4 2022. 65 funds tracked by Wall St. Rank hold SGHT as of Q3 2023.

PDT Partners reported no remaining Sight Sciences position as of Q3 2023 after selling out during the quarter.
PDT Partners sold 15,971 Sight Sciences shares in Q3 2023, an estimated $132K.
PDT Partners first reported a position in Sight Sciences in Q4 2022 and held it in 3 quarters.
PDT Partners's Sight Sciences position peaked at $173K in Q4 2022.
65 funds tracked by Wall St. Rank held Sight Sciences as of Q3 2023.

Based on PDT Partners's 13F filing for Q3 2023, filed 14 Nov 2023.